Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Oregovomab |
Trade Name | |
Synonyms | B43.13 |
Drug Descriptions |
Oregovomab is a monoclonal antibody which targets the tumor antigen MUC16 (CA125) promoting an immune response (PMID: 31916979). |
DrugClasses | MUC16 Targeted Therapy 10 |
CAS Registry Number | 213327-37-8 |
NCIT ID | C1784 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Oregovomab + Paclitaxel | Carboplatin Oregovomab Paclitaxel | 0 | 2 |
Niraparib + Oregovomab | Niraparib Oregovomab | 0 | 1 |
Oregovomab | Oregovomab | 0 | 1 |
Oregovomab + Poly ICLC | Oregovomab Poly ICLC | 0 | 1 |